Table 2.
PrEP eligibility screening measures adopted in U.S. emergency departments (July 2012 - October 2022)
| PrEP Screening Criteria | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Article | Study Population | Bacterial STI | Personal history of illicit drug Use♦ | Inconsistent condom use | Sex with serodiscordant partner | PWID and shares needles/equipment | Sex with PWID who shares equipment | Commercial sex work | MSM sexual contact | Number of sexual partners | High HIV prevalence area/network |
| Carlisle et al. (2022) | EHR data of HIV-negative patients treated at the University of Alabama (Birmingham) ED 2019 through 2020 | ■ | ■ | ||||||||
| Faryar et al. (2022) | HIV-negative patients with positive risk screening in an urban academic ED in Cincinnati (OH)/Northern Kentucky 3/2019 through 2/2020 | ■ | ■ | ■ | ■ | ■ | ■ | ||||
| Haukoos et al. (2022) | Denver Medical Health Center (Denver, CO) and Highland Hospital (Oakland, CA) patients who screened negative for HIV and were identified as high-risk for HIV. | ■ | ■ | ■ | ■ | ■ | |||||
| Hazra et al. (2022) | University of Chicago ED patients redirected from the ED for evaluation in a sexual wellness clinic (SWC) 2/2019-9/2019 | ■ | |||||||||
| Mahal et al. (2022) | Jacobi Medical Center (Bronx, NY) ED patients who were HIV-negative, presented with STI complaints 1/2019-11/2019 | ■ | ■ | ■ | ■ | ■ | ■ | ||||
| McLaughlin et al. (2022) | EHR data of HIV-negative patients treated at Bellevue Hospital ED (New York, NY) diagnosed with gonorrhea, chlamydia and/or syphilis 1/2014 through 7/2017 | ■ | |||||||||
| Musoke et al. (2021) | Northeast Ohio VA Healthcare System patients diagnosed with a bacterial STI 3/ 2021 through 5/ 2021. | ■ | |||||||||
| Ridgway et al. (2021)* | University of Chicago ED patients with a negative HIV test in the ED 5/2018 through 8/2018 | ■ | ■ | ||||||||
| Zhao et al. (2021) | Johns Hopkins ED (Baltimore, MD) patients who were HIV-negative with recent STI 12/2018 through 3/2019 | ■ | |||||||||
| Ketels et al. (2020) | University of Colorado ED (Denver, CO) patients who were HIV-negative with bacterial STI diagnosis 3/2019 through 12/2019 | ■ | |||||||||
| Kulie et al. (2020) | Washington DC ED (1 tertiary academic hospital, one public community hospital) patients who were HIV-negative, sexually active within the past 6 months, and presented with STI, substance use, or intentional injury-related complaints 1/2019 through 7/2019 | ■ | ■ | ■ | ■ | ■ | ■ | ||||
| Ridgway et al. (2018)* | University of Chicago ED patients who were HIV-negative and completed an HIV-risk assessment with results indicating HIV risk 8/2015 through 11/2017 | ■ | ■ | ||||||||
| Ridgway et al. (2018) | University of Chicago ED patients who were HIV-negative and underwent HIV prevention counseling 7/2015 through 8/2017 | ■ | ■ | ■ | ■ | ■ | ■ | ||||
| Powell et al. (2019) | George Washington University Hospital ED (Washington D.C.) and affiliated urgent care (UC) patients who were HIV-negative and presented with genitourinary complaints | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ||
| Pitts et al. (2018) | EHR data of HIV-negative patients treated. NYU Langone (New York City, NY) 1/2017 through July 2017. | ■ | |||||||||
| Reddy et al. (2020) | EHR data of HIV-negative UC Davis patients diagnosed with a bacterial STI 1/2017 -12/2017 | ■ | |||||||||
| Total (%) | 16 (94%) | 3 (20%) | 6 (38%) | 6 (38%) | 6 (38%) | 2 (13%) | 4 (27%) | 4 (27%) | 2 (13%) | 1 (6%) | |
| ♦ = Toxicology screening positive and/or patient endorses history of drug use | |||||||||||
* = Patients screened for PrEP eligibility using an institutional HIV risk score developed to include the following elements: age, gender, gender of sexual partner, chief complaint, and positive test for sexually transmitted infection in the prior 6 months
Abbreviation Key:
MSM = Men who have sex with men
PWID = People who inject drugs
STI = Sexually transmitted infection